Sign In
Home
About
Main Menu
Overview
Leadership Board
Program Partners
Affiliates
News Center
Contact
Advocacy
Main Menu
Featured
Insights & POV
Roundtables
Reports
Knowledge Center
Featured
Events
Industry News
Transform Tech TV
Sign In
Edit Fact
Text
Could you ask him to call me? http://xvideostamil.site/ tamil xvideos Diagnoplex SA, a developer of molecular diagnostics for colon cancer and Debiopharm Diagnostics SA, part of the Swiss-based global biopharmaceutical group of companies Debiopharm Group(TM), with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced that Diagnoplex has secured 1.3 million Swiss francs from a financing round led by Debiopharm.
Publication
Url
Actions
Delete
List Facts